Broadley-James Ltd is pleased to support the 12th Annual bioProcessUK conference at the Wellcome Genome Campus, Hinxton, Cambridge, UK, 25 – 26th November 2015.
Dr Jane Osbourn, Vice President R&D and Cambridge Site Leader, MedImmmune will open the conference and with an expected audience of 300+ delegates from the biological medicines sector in the UK and Ireland, this packed two-day event is a must-attend conference for those involved in this exciting sector.
With a plethora of keynote presentations, panel discussions, workshops, poster presentations from young researchers, one-to-one speed partnering and a packed exhibition hall there is something for everyone.